Cargando…
Current data on IL-17 and Th17 cells and implications for graft versus host disease
Human interleukin 17 was first described in 1995 as a new cytokine produced primarily by activated T CD4+ cells that stimulate the secretion of IL-6 and IL-8 by human fibroblasts, besides increasing the expression of ICAM-1. Various authors have reported that IL-17A has a role in the protection of o...
Autores principales: | Normanton, Marília, Marti, Luciana Cavalheiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872902/ https://www.ncbi.nlm.nih.gov/pubmed/23843069 http://dx.doi.org/10.1590/S1679-45082013000200019 |
Ejemplares similares
-
IL-17 Genetic and Immunophenotypic Evaluation in Chronic Graft-versus-Host Disease
por: Resende, Renata Gonçalves, et al.
Publicado: (2014) -
Diverse Activity of IL-17(+) Cells in Chronic Skin and Mucosa Graft-Versus-Host Disease
por: Klimczak, Aleksandra, et al.
Publicado: (2019) -
IL-17A and Th17 Cells in Lung Inflammation: An Update on the Role of Th17 Cell Differentiation and IL-17R Signaling in Host Defense against Infection
por: Tsai, Hsing-Chuan, et al.
Publicado: (2013) -
Interleukin 7 Plays a Role in T Lymphocyte Apoptosis Inhibition Driven by Mesenchymal Stem Cell without Favoring Proliferation and Cytokines Secretion
por: Normanton, Marilia, et al.
Publicado: (2014) -
Role of IL-17 and Th17 Cells in Liver Diseases
por: Hammerich, Linda, et al.
Publicado: (2011)